A twisting tale of misinformation: should ivermectin be approved as a treatment for COVID-19 disease?-Reference-Cited by-全球学者库

A twisting tale of misinformation: should ivermectin be approved as a treatment for COVID-19 disease?

Published:2023-02 Issue:3 Volume:18 Page:137-139
ISSN:1746-0794
Container-title:Future Virology
language:en
Short-container-title:Future Virology

Author:

Shafiee Arman¹²^ORCID,Teymouri Athar Mohammad Mobin³^ORCID,Mozhgani Sayed-Hamidreza⁴⁵^ORCID

Affiliation:

1. Clinical Research Development Unit, Alborz University of Medical Sciences, Karaj, Iran

2. Student Research Committee, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran

3. School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

4. Department of Microbiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran

5. Non-communicable Disease Research Center, Alborz University of Medical Sciences, Karaj, Iran

Abstract

Tweetable abstract This editorial examines what has caused the evidence around ivermectin to be so controversial, provides a brief analysis of recently published evidence, and highlights why it is important to learn lessons from ivermectin for future re-purposed drugs.

Publisher

Future Medicine Ltd

Subject

Virology

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fvl-2023-0006

Reference20 articles.

1. Can anti-parasitic drugs help control COVID-19?

2. Ivermectin: A Controversial Focal Point during the COVID-19 Pandemic

3. Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach

4. Latin America’s embrace of an unproven COVID treatment is hindering drug trials

5. From hydroxychloroquine to ivermectin: how unproven “cures” can go viral

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Likes and Retweets Impacted Our Patients During the COVID-19 Pandemic;The Journal of Allergy and Clinical Immunology: In Practice;2023-11